Sourasky Medical Center (Ichilov)
Bookimedは膵嚢胞治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。膵嚢胞治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。膵嚢胞治療の旅路でお一人になることはありません。
Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.
She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.
Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.
Israeli specialists use high-resolution MRI and MRCP imaging to map connections to the pancreatic duct. They perform endoscopic ultrasound with fine-needle aspiration to analyze cyst fluid for tumor markers and genetic mutations. Cases are reviewed by multidisciplinary tumor boards at JCI-accredited facilities to prevent unnecessary surgery.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Sheba prioritize precision diagnostics to avoid overtreatment. Specialists like Dr. Einat Shacham Shmueli use specific biomarkers to distinguish benign from precancerous cells. This focus on molecular profiling ensures that surgery like the Whipple procedure is only performed when necessary.
Patient Consensus: Patients note that endoscopic ultrasound is often the decisive step when initial scans are unclear. They emphasize sharing detailed family history and prior pancreatitis records to help specialists assess individual risk levels.
Most pancreatic cysts do not require immediate surgery or removal. Israeli medical centers prioritize active surveillance for low-risk, asymptomatic cysts. Specialists reserve surgery for lesions exceeding 3 centimeters or those showing suspicious growth, solid nodules, or main pancreatic duct dilation during monitoring.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report a 90% success rate for complex pancreatic treatments. Data suggests surgery is rarely the first step. Surgeons with 20+ years of experience, such as Dr. Ron Greenberg, often use digital imaging to verify if a cyst is truly high-risk before operating.
Patient Consensus: Patients note that while the fear of cancer is stressful, getting a second opinion through a biopsy often reveals the cyst is benign. Many emphasize the importance of choosing a surgeon experienced in minimally invasive techniques to avoid long recovery times.
Minimally invasive and robotic surgeries are widely available for pancreatic cyst treatment in Israel. Specialized centers use laparoscopic techniques and the da Vinci surgical system. These methods help reduce blood loss. They also speed up recovery times compared to traditional open surgery.
Bookimed Expert Insight: Israeli hospitals like Sourasky Medical Center manage over 400,000 patients annually with 90% oncology success. Data shows robotic surgery significantly shortens recovery. A robotic distal pancreatectomy usually requires only 4 hospital days. Open surgery often requires 2 full weeks of inpatient care. This 10-day difference makes robotic options highly sought after for international patients.
Patient Consensus: Patients emphasize getting a second opinion with recent imaging. They note that robotic surgery is excellent for complex cysts, but open surgery remains safer for some specific cases.
Israel offers advanced non-surgical therapies for pancreatic lesions, including EUS-guided radiofrequency ablation (EUS-RFA), irreversible electroporation (NanoKnife), and targeted alpha-radiation (Alpha DaRT). These techniques target cysts and tumors while sparing healthy tissue. Leading centers like Sourasky and Sheba provide these minimally invasive options.
Bookimed Expert Insight: Israeli specialists often combine advanced diagnostics with personalized therapy. Dr. Einat Shacham Shmueli at Sheba Medical Center focuses on biomarkers to tailor these non-surgical interventions. Data from Sourasky Medical Center shows a 90% oncology success rate. This level of precision helps determine if EUS-RFA or ethanol injection is the safer choice for specific cyst types.
Patient Consensus: Patients value EUS-RFA for its quick recovery, often returning to work within days. Many emphasize getting a cyst fluid analysis first to ensure the therapy fits their specific condition.
Leading Israeli hospitals for pancreatic care include Sheba Medical Center and Tel Aviv Sourasky Medical Center. These JCI-accredited facilities specialize in advanced diagnostics and complex surgeries like the Whipple procedure. They maintain over 90% success rates for oncology treatments using multidisciplinary tumor board reviews.
Bookimed Expert Insight: Sourasky Medical Center handles over 1.8 million patients annually. Our data shows it ranks among the top 10 most popular clinics globally. This high volume allows surgeons like Dr. Ron Greenberg to maintain expertise in both open and minimally invasive procedures. Choosing high-capacity centers often ensures access to specialized surgical departments that perform rare revisions.
Patient Consensus: Patients note that seeking a second opinion via MRI or EUS biopsy remote review often helps avoid unnecessary surgeries. Many emphasize that robotic-assisted procedures at Sheba allow for a faster 2-week recovery compared to standard surgical methods.